Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells.

IF 2.5 4区 医学 Q3 ONCOLOGY
Oncology Letters Pub Date : 2014-10-01 Epub Date: 2014-07-09 DOI:10.3892/ol.2014.2328
San-Lin Lei, Hua Zhao, Hong-Liang Yao, Yong Chen, Zhen-Dong Lei, Kui-Jie Liu, Qun Yang
{"title":"Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells.","authors":"San-Lin Lei,&nbsp;Hua Zhao,&nbsp;Hong-Liang Yao,&nbsp;Yong Chen,&nbsp;Zhen-Dong Lei,&nbsp;Kui-Jie Liu,&nbsp;Qun Yang","doi":"10.3892/ol.2014.2328","DOIUrl":null,"url":null,"abstract":"<p><p>MicroRNAs (miRs) function as key regulators of gene expression and their deregulation is associated with the carcinogenesis of various cancers. In the present study, the aim was to validate the potential roles and regulatory mechanisms of miR-708 and miR-31 in colorectal cancer (CRC) cells. miR-708 and miR-31 were found to be highly expressed in five CRC tissue samples. Functional studies showed that the inhibition of miR-708 and miR-31 inhibited cell proliferation and invasion, however, promoted apoptosis <i>in vitro</i>. Subsequently, it was identified that miR-708 and miR-31 directly target cyclin-dependent kinase inhibitor 2B (CDKN2B) by binding to the 3' untranslated region, which suppresses the CDKN2B protein levels. In addition, the CDKN2B protein levels were significantly reduced when there was high miR-708 and miR-31 expression in the CRC tissue samples. The results indicate that miR-31 and miR-708 function in an oncogenic manner in CRC development, and inhibition of the two miRs may be used as a therapeutic strategy for patients with CRC.</p>","PeriodicalId":19503,"journal":{"name":"Oncology Letters","volume":"8 4","pages":"1768-1774"},"PeriodicalIF":2.5000,"publicationDate":"2014-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3892/ol.2014.2328","citationCount":"49","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Letters","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ol.2014.2328","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/7/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 49

Abstract

MicroRNAs (miRs) function as key regulators of gene expression and their deregulation is associated with the carcinogenesis of various cancers. In the present study, the aim was to validate the potential roles and regulatory mechanisms of miR-708 and miR-31 in colorectal cancer (CRC) cells. miR-708 and miR-31 were found to be highly expressed in five CRC tissue samples. Functional studies showed that the inhibition of miR-708 and miR-31 inhibited cell proliferation and invasion, however, promoted apoptosis in vitro. Subsequently, it was identified that miR-708 and miR-31 directly target cyclin-dependent kinase inhibitor 2B (CDKN2B) by binding to the 3' untranslated region, which suppresses the CDKN2B protein levels. In addition, the CDKN2B protein levels were significantly reduced when there was high miR-708 and miR-31 expression in the CRC tissue samples. The results indicate that miR-31 and miR-708 function in an oncogenic manner in CRC development, and inhibition of the two miRs may be used as a therapeutic strategy for patients with CRC.

Abstract Image

Abstract Image

Abstract Image

microRNA-708和microRNA-31在结直肠癌细胞增殖、凋亡和侵袭中的调控作用。
MicroRNAs (miRs)是基因表达的关键调控因子,其失调与各种癌症的致癌有关。在本研究中,目的是验证miR-708和miR-31在结直肠癌(CRC)细胞中的潜在作用和调节机制。miR-708和miR-31在5个结直肠癌组织样本中高表达。功能研究表明,抑制miR-708和miR-31在体外抑制细胞增殖和侵袭,但促进细胞凋亡。随后,我们发现miR-708和miR-31通过结合3'非翻译区直接靶向细胞周期蛋白依赖性激酶抑制剂2B (CDKN2B),从而抑制CDKN2B蛋白水平。此外,当CRC组织样本中miR-708和miR-31高表达时,CDKN2B蛋白水平显著降低。结果表明,miR-31和miR-708在结直肠癌的发展中以致癌方式起作用,抑制这两种mir可能被用作结直肠癌患者的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Oncology Letters
Oncology Letters ONCOLOGY-
CiteScore
5.70
自引率
0.00%
发文量
412
审稿时长
2.0 months
期刊介绍: Oncology Letters is a monthly, peer-reviewed journal, available in print and online, that focuses on all aspects of clinical oncology, as well as in vitro and in vivo experimental model systems relevant to the mechanisms of disease. The principal aim of Oncology Letters is to provide the prompt publication of original studies of high quality that pertain to clinical oncology, chemotherapy, oncogenes, carcinogenesis, metastasis, epidemiology and viral oncology in the form of original research, reviews and case reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信